Transaction to include felzartamab, a potential first-in-class therapeutic candidate with promise as a pipeline-in-a-product across a range of immune-mediated diseasesFelzartamab is an investigational.
Transaction to include felzartamab, a potential first-in-class therapeutic candidate with promise as a pipeline-in-a-product across a range of immune-mediated diseasesFelzartamab is an investigational
Dividend stocks are gaining traction among seasoned as well as retail investors this year. The addition of some of the biggest tech names, such as Meta Platforms, Inc. (NASDAQ:META), Salesforce, Inc.